Jörg Haupenthal

2.3k total citations
72 papers, 1.7k citations indexed

About

Jörg Haupenthal is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Jörg Haupenthal has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 14 papers in Organic Chemistry and 12 papers in Genetics. Recurrent topics in Jörg Haupenthal's work include Antibiotic Resistance in Bacteria (11 papers), Antimicrobial Peptides and Activities (10 papers) and Bacterial biofilms and quorum sensing (9 papers). Jörg Haupenthal is often cited by papers focused on Antibiotic Resistance in Bacteria (11 papers), Antimicrobial Peptides and Activities (10 papers) and Bacterial biofilms and quorum sensing (9 papers). Jörg Haupenthal collaborates with scholars based in Germany, Austria and Netherlands. Jörg Haupenthal's co-authors include Rolf W. Hartmann, Albrecht Piiper, Stefan Zeuzem, Anna K. H. Hirsch, Bernd Kronenberger, Oliver Waidmann, Jan Peveling‐Oberhag, Matthias F. Groh, Ricardo M. Biondi and Walid A. M. Elgaher and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Jörg Haupenthal

71 papers receiving 1.7k citations

Peers

Countries citing papers authored by Jörg Haupenthal

Since Specialization

Citations

This map shows the geographic impact of Jörg Haupenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Haupenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Haupenthal more than expected).

Fields of papers citing papers by Jörg Haupenthal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Haupenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Haupenthal. The network helps show where Jörg Haupenthal may publish in the future.

Co-authorship network of co-authors of Jörg Haupenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Haupenthal. A scholar is included among the top collaborators of Jörg Haupenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Haupenthal. Jörg Haupenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modular synthetic routes to biologically active indoles from lignin 2025 ·Green Chemistry ·(unknown), Jörg Haupenthal, Anna K. H. Hirsch, Katalin Barta	2
2	Innovative zinc-binding inhibitors of Legionella pneumophila ProA reduce collagen and flagellin degradation, TLR5 evasion, and human lung tissue inflammation 2025 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Christian G. Schütz, Guillermo Bianchi, (unknown), Jörg Haupenthal, (unknown), (unknown), Ruoyu Zhang, Wulf Blankenfeldt, Anna K. H. Hirsch, Michael Steinert	0
3	Dual inhibitors of Pseudomonas aeruginosa virulence factors LecA and LasB 2024 ·Chemical Science ·(unknown), (unknown), Andreas Klein, (unknown), Mario A. Fares, (unknown), Samir Yahiaoui, Walid A. M. Elgaher, Jörg Haupenthal, Alexander Titz, Anna K. H. Hirsch	8
4	Target-Directed Dynamic Combinatorial Chemistry Affords Binders of Mycobacterium tuberculosis IspE 2024 ·ACS Omega ·(unknown), (unknown), (unknown), Jörg Haupenthal, Andreas M. Kany, Eleonora Diamanti, (unknown), Norbert Reiling, Wulf Blankenfeldt, (unknown), Anna K. H. Hirsch	2
5	Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity 2024 ·Journal of Medicinal Chemistry ·(unknown), Katharina J. Hoff, (unknown), Yunqi Li, Jörg Haupenthal, Andreas M. Kany, (unknown), (unknown), Katharina Rox, Anna K. H. Hirsch, Isabelle Krimm, Wolfgang Sippl, Ralph Holl	2
6	Development and evaluation of 2,4‐disubstituted‐5‐aryl pyrimidine derivatives as antibacterial agents 2024 ·Archiv der Pharmazie ·(unknown), (unknown), Jörg Haupenthal, Jennifer Herrmann, (unknown), Alireza Abadi, Matthias Engel, Rolf Müller, Anna K. H. Hirsch, Mohammad Abdel‐Halim, Mostafa M. Hamed	4
7	Expression and characterization of pantothenate energy‐coupling factor transporters as an anti‐infective drug target 2024 ·Protein Science ·(unknown), (unknown), Eleonora Diamanti, Walid A. M. Elgaher, (unknown), Jörg Haupenthal, Dirk Jan Slotboom, Anna K. H. Hirsch	2
8	Spray drying of a zinc complexing agent for inhalation therapy of pulmonary fibrosis 2024 ·European Journal of Pharmaceutical Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), Jörg Haupenthal, Anna K. H. Hirsch, Marc Schneider	2
9	Exploring the Translational Gap of a Novel Class of Escherichia coli IspE Inhibitors 2023 ·ChemMedChem ·(unknown), Eleonora Diamanti, Sandra Johannsen, Boris Illarionov, (unknown), (unknown), Peter Saß, Markus Fischer, Jörg Haupenthal, Anna K. H. Hirsch	3
10	Clean Synthetic Strategies to Biologically Active Molecules from Lignin: A Green Path to Drug Discovery** 2023 ·Angewandte Chemie ·Anastasiia M. Afanasenko, (unknown), Alessandra De Santi, Walid A. M. Elgaher, Andreas M. Kany, (unknown), (unknown), Thomas F. Schulz, Jörg Haupenthal, Anna K. H. Hirsch, Katalin Barta	8
11	Discovery of novel drug-like antitubercular hits targeting the MEP pathway enzyme DXPS by strategic application of ligand-based virtual screening 2022 ·Chemical Science ·Di Zhu, Sandra Johannsen, Tiziana Masini, (unknown), Jörg Haupenthal, Boris Illarionov, (unknown), Mahendra Awale, (unknown), Tridia van der Laan, (unknown), (unknown), (unknown), Eric Buhler, Norbert Reiling, Rolf Müller, Markus Fischer, Jean‐Louis Reymond, Anna K. H. Hirsch	10
12	Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa 2022 ·ACS Infectious Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Esther Schönauer, Asfandyar Sikandar, Jörg Haupenthal, Rolf Müller, Hans Brandstetter, Rolf W. Hartmann, Anna K. H. Hirsch	12
13	Hit-optimization using target-directed dynamic combinatorial chemistry: development of inhibitors of the anti-infective target 1-deoxy- d -xylulose-5-phosphate synthase 2021 ·Chemical Science ·Ravindra P. Jumde, (unknown), (unknown), (unknown), Di Zhu, (unknown), Sandra Johannsen, Walid A. M. Elgaher, (unknown), Christian Nehls, Jörg Haupenthal, Norbert Reiling, Anna K. H. Hirsch	25
14	N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa 2021 ·RSC Medicinal Chemistry ·Samir Yahiaoui, (unknown), Jörg Haupenthal, Thomas A. Wichelhaus, Denia Frank, Lilia Weizel, (unknown), (unknown), Jan S. Kramer, Ewgenij Proschak, Christian Ducho, Anna K. H. Hirsch	10
15	Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis 2019 ·Journal of Controlled Release ·(unknown), Eric Ofosu Kissi, Walid A. M. Elgaher, (unknown), Jörg Haupenthal, Bianca Schwarz, Anna K. H. Hirsch, Thomas Rades, Marc Schneider	42
16	Discovery of a Potent Inhibitor Class with High Selectivity toward Clostridial Collagenases 2017 ·Journal of the American Chemical Society ·Esther Schönauer, Andreas M. Kany, Jörg Haupenthal, (unknown), (unknown), (unknown), Samir Yahiaoui, Brigitta Elsässer, Christian Ducho, Hans Brandstetter, Rolf W. Hartmann	29
17	Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: A legitimate approach 2012 ·European Journal of Medicinal Chemistry ·Saurabh Aggarwal, Suresh Thareja, Tulika Bhardwaj, Jörg Haupenthal, Rolf W. Hartmann, (unknown)	16
18	RNAse A‐like enzymes in serum inhibit the anti‐neoplastic activity of siRNA targeting polo‐like kinase 1 2007 ·International Journal of Cancer ·Jörg Haupenthal, (unknown), Stefan Zeuzem, Albrecht Piiper	38
19	Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum 2006 ·Biochemical Pharmacology ·Jörg Haupenthal, (unknown), (unknown), Stefan Zeuzem, Albrecht Piiper	132
20	Epac Activation Converts cAMP from a Proliferative into a Differentiation Signal in PC12 Cells 2005 ·Molecular Biology of the Cell ·(unknown), Ricardo M. Biondi, Jochen Imig, Guido Plotz, Jörg Haupenthal, Stefan Zeuzem, Albrecht Piiper	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact